HMP Global Learning Network

4 weeks ago | hmpgloballearningnetwork.com | Viet Le

WASHINGTON - Intermountain Health cardiovascular clinician and researcher Viet Le, DMSc, MPAS, PA-C, FACC, will serve as the next editor of the American College of Cardiology's CardioSmart program. Le is the first non-physician leader of the program. "Many Challenges Facing Cardiology PAs Can Be Solved With Networking" by Viet Le, DMSc, MPAS, PA-C, FACCACC's CardioSmart is a patient engagement program that provides helpful tools to better understand heart health.

2 months ago | hmpgloballearningnetwork.com | Hannah Musick

A recent real-world analysis comparing chimeric antigen receptor (CAR) T-cell therapy to standard non–CAR T treatments for relapsed/refractory mantle cell lymphoma (R/R MCL) found that patients receiving CAR T therapy experienced fewer follow-up treatments, longer treatment-free intervals, and reduced health care costs. The study included 2835 patients treated with non–CAR T standard of care and 122 patients treated with CAR T therapy, all with at least 2 prior lines of therapy.

2 months ago | hmpgloballearningnetwork.com | Neil Shah

In this interview, Dr Neil Shah discusses the challenges of treatment sequencing for metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitor therapy, highlighting findings from his study on post-IO treatment efficacy and the need for novel therapeutic options. Read the full transcript below:Please introduce yourself by stating your name, title, and any relevant clinical experience. Neil Shah, MD: I'm Neil Shah.

2 months ago | hmpgloballearningnetwork.com | Jessica Garlewicz

A recent study published in RMD Open, evaluating patients with psoriasis (PsO) and subclinical psoriatic arthritis (PsA), highlights the elevated risk of developing PsA in this population. The findings emphasize the importance of monitoring musculoskeletal symptoms in patients with PsO to facilitate early detection and intervention. The study followed 384 patients with PsO for an average of 33 months, with 311 (80.9%) classified as having subclinical PsA.

2 months ago | hmpgloballearningnetwork.com | Eric A. Secemsky

In this video from CRT 2025, JIC speaks with Dr Eric Secemsky of the Beth Israel Deaconness Medical Center about the future of renal denervation in atrial fibrillation treatment. Transcript:Hi, I'm Eric Secemsky. I'm an interventional cardiologist at the Beth Israel Deaconess Medical Center in Boston, Massachusetts. Can you please briefly explain the physiological link between the renal system and AFib?